BioStem Technologies, Inc. (OTC: BSEM) Appoints David Wolfe and Dr. Michael Beckwith to Its Advisory Board
May 27 2016 - 10:30AM
Marketwired
BioStem Technologies, Inc. (OTC: BSEM) Appoints David Wolfe and
Dr. Michael Beckwith to Its Advisory Board
OAKLAND PARK, FL-(Marketwired - May 27, 2016) - BioStem
Technologies, Inc. ("BioStem" or the "Company") (OTC PINK: BSEM)
today announced the appointment of David Wolfe and Rev. Michael
Bernard Beckwith to its Advisory Board. The Advisory Board of the
Company provides advice and guidance to the Board of Directors of
the Company, but Advisory Board members are not Directors of the
Corporation. Mr. Wolfe and Dr. Beckwith are both well-known opinion
leaders in their respective fields.
David "Avocado" Wolfe is a leading educator and 22-year promoter
of superfoods that impact longevity, and he has consulted for the
world's top CEOs, ambassadors, celebrities, athletes, artists (and
Moms, of course). He is the co-developer and spokesperson for the
NUTRiBULLET, which is now the nation's #1 selling kitchen
appliance. He is also the co-founder of TheBestDayEver.com online
health magazine and the Founder and President of the non-profit The
Fruit Tree Planting Foundation charity (www.ftpf.org), which has a
mission to plant 18 billion fruit, nut, and medicinal trees around
the world.
Reverend Michael Beckwith has authored eight books, produced
three movies, and co-authored 120 songs. Dr. Beckwith's notoriety
climbed through the production of the very successful film The
Secret (2006). He was a regular guest of the Oprah Winfrey and
Larry King television programs, and his weekly Friday afternoon
radio program on the Los Angeles station, KPFK, is hugely popular.
Dr. Beckwith's humanitarian efforts have attracted numerous awards
including the 1999 Humanitarian Award from the National Conference
for Compassion and Justice, the 2001 Gandhi-King-Ikeda Award from
Morehouse College, the 2004 Africa Achievement Peace Award, the
2006 Black Aids Institute Hero Award; and in 2009, the Ebony
Magazine's 150 Award. In 1999 he was inducted into the Assembly of
the Parliament of the World's Religions.
Henry Van Vurst, BioStem's CEO went on to say, "We could not be
more pleased to have Michael Beckwith and David Wolfe joining the
team. I strongly believe that the addition of these world-renowned
thought leaders will further insure BioStem Technologies' mission
of being the Global Leader in Anti-Aging and Regenerative Medicine.
Both of these individuals bring a sense of enthusiasm and depth of
understanding for the overall wellness of people that is imperative
at BioStem Technologies."
About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem
Technologies (OTC PINK: BSEM) is in the business of regenerative
medicine and antiaging strategies throughout the United States,
Europe, and Mexico. The Company's mission is to conquer the effects
of biological aging (and related acute disease), and its strategy
is to discover, develop, produce, and deliver the most effective
stem cell and wellness products in the world. The Company is
comprised of a diverse group of scientists, physicians, and
industry visionaries who are creating innovative products for
helping customers live their best, feel their best, and be their
best. The company operates four strategic business units - BioStem
Cell Therapy, BioStem Wellness, BioStem Pharmaceuticals, and
BioStem International - providing a diversified line of products
and services that include: clinical stem cell therapy, stem cell
R&D, state-of-the-art laboratory services, pharmaceuticals,
nutraceuticals, cosmeceuticals, API Repackaging, and medical
tourism.
Forward-Looking Statements Except for statements of historical
fact, the matters discussed in this press release are forward
looking and made pursuant to the Safe Harbor provisions of the
Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "future,"
"plan" or "planned," "expects," believe" or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with OTC Markets.
Contact Information
Contact: BioStem Technologies, Inc. Phone: 954-380-8342 Website:
http://www.biostemtech.com Email: info@biostemtech.com Twitter:
@Biostemtech Facebook: Biostem Technologies
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Jul 2024 to Aug 2024
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Aug 2023 to Aug 2024